Skip to main content
. 2020 Dec 16;37(4):e2020009. doi: 10.36141/svdld.v37i4.10726
Covid Positive Covid negative Percent with feature Percent COVID positive Hazards ratio 95% CI P Comments
ALL PATIENTS
Sarcoidosis 13 1603 1616 0.80%
Sarc patients
Male 2 275 277 14.11% 0.72% 0.4545 0.1003-2.0624 >0.10
Female 10 620 630 32.09% 1.59% 709 no sex indicated
Black 3 90 93 4.89% 3.23% 2.817 0.7764-10.2227 >0.10
White 9 777 786 41.30% 1.15% 826 patients biracial
Roommate with COVID
yes 2 3 5 0.25% 40.00% 58.5818 17.2179-1999.317 <0.0001
no 11 1600 1611 82.07% 0.68%
Health care provider
Yes 1 82 83 4.23% 1.20% 1.5392 0.2025-11.6963 >0.10
no 12 1521 1533 78.09% 0.78%
Current meds * If no response, assume
Prednisone 5 318 323 16.38% 1.55% 2.5019 0.824-7.5971 >0.10 drug not used
No prednisone 8 1285 1293 65.57% 0.62%
Plaquenil 0 115 115 5.83% 0.00% 0.4572 0.02735-7.6429 >0.10
No plaquenil 13 1418 1431 72.57% 0.91%
anti-TNF 1 115 116 5.88% 0.86% 1.0273 0.1348-7.8316 >0.10
no anti- TNF 12 1418 1430 72.52% 0.84%
Cytotoxic 2 272 274 13.89% 0.73% 0.8905 0.1985-3.9952 >0.10
No cytotoxic 11 1331 1342 68.05% 0.82%
Rituximab 1 10 11 0.56% 9.09% 12.1515 1.7255-85.5785 0.0122
No rituximab 12 1592 1604 81.34% 0.75%
Underlying
COPD 3 177 180 9.13% 1.67% 2.3933 0.6648-8.6150 >0.10
10 1426 1436 72.82% 0.70%
1616
Diabetes 1 134 135 6.85% 0.74% 0.9142 0.1198-6.9776 >0.10
12 1469 1481 75.10% 0.81%
1616
Heart disease 1 116 117 5.93% 0.85% 1.067 0.14-8.1402 >0.10
12 1487 1499 76.01% 0.80%
1616
Hypertension 4 275 279 14.15% 1.43% 2.1298 0.6605-6.8673 >0.10
9 1328 1337 67.80% 0.67%
1616
Organ involved* If no response, assume
Lung 10 728 738 37.42% 1.36% 3.9657 1.0954-14.3563 0.0358 not involved
3 875 878 44.52% 0.34%
1616
Cardiac sarc 1 12 13 0.66% 7.69% 9.4551 1.3244-67.5027 0.0251
12 1463 1475 74.80% 0.81%
1488
Neuro sarc 4 84 88 4.46% 4.55% 7.7172 2.424-24.5693 0.0005
9 1519 1528 77.48% 0.59%
1616
Origin
US NA NA 0 0.00% #VALUE! NOT AVAILABLE
non US NA NA 0 0.00% #VALUE!
0
Sarcoid age
Covid Positive 54.4 ± 11.29 years >0.10
Covid negative 56.6 ± 10.39 years
Sarc ≥ 5 yr 8 720 728 38.14% 1.10% 0.5357 0.163-1.7602 >0.01 Information missing on 986 patients
Sarc < 5 yr 4 191 195 10.21% 2.05%
COVID outcome Home Hospital ICU Vent
Sarc 8 3 0 0 2 no information
#REF!
COVID positive Home Hospital If in hospital, considered
Prednisone bad outcome
Yes 3 1 4 6.06% 75.00% 1.05 0.5037-2.1889 >0.10 Hazard ration for
No 5 2 7 10.61% 71.43% Hospitalization
Infliximab
Yes 0 0 0 0.00% 0.00% 0.7059 0.09617-5.1812 >0.10
No 8 3 11 16.67% 72.73%
Plaquenil
Yes 0 0 0 0.00% 0.00% 0.7059 0.09617-5.1812 >0.10
No 8 3 11 16.67% 72.73%
Cytotoxic
Yes 1 0 1 1.52% 100.00% 1.4286 0.9512-2.1435 0.0849
No 7 3 10 15.15% 70.00%
Rituximab
Yes 0 1 1 1.52% 0.00% 0.3235 0.02872-3.6449 >0.10
No 8 2 10 15.15% 80.00%